ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1874

Development of an Ultrasonographic Enthesitis Score for Psoriatic Arthritis Patients

Stephanie Tom1,2, Yujie Zhong3, Richard J. Cook4, Sibel Z. Aydin5,6, Gurjit S. Kaeley7 and Lihi Eder8,9, 1Women's College Hospital, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom, 4Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, ON, Canada, 5The Ottawa Hospital, Ottawa, ON, Canada, 6University of Ottawa, Ottawa, ON, Canada, 7University of Florida, Ponte Vedra Beach, FL, 8Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada, 9Medicine, University of Toronto, Toronto, ON, Canada

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Enthesitis, Psoriatic arthritis, spondylarthritis and ultrasonography

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Imaging of Rheumatic Diseases I: Novel Imaging and Scoring Systems

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Enthesitis affects approximately a third of patients with psoriatic arthritis (PsA) and is often considered the earliest site of inflammation. The accuracy of clinical examination of enthesitis is limited. Ultrasound could improve detection of enthesitis, however, there is no accepted score for assessment of sonographic enthesitis in PsA. The objective of this study is to assess the performance of various sonographic elemental entheseal lesions in distinguishing between PsA and healthy controls which will inform the development of a novel sonographic enthesitis score for PsA.

Methods: A total of 100 age- and sex-matched individuals (50 PsA and 50 controls) were recruited for this cross-sectional study. Patients with PsA were recruited during their clinic visits. Healthy controls with no personal or family history of inflammatory arthritis were recruited from hospital personnel and advertisements. Eleven entheseal sites were scanned bilaterally according to a standardized protocol by two sonographers. The selection of entheseal sites for this study was based on systematic literature review and expert opinion of rheumatologists experienced in musculoskeletal ultrasound in PsA. Based on OMERACT definition of sonographic enthesitis, the following lesions were assessed: structural changes, thickness, erosion, enthesophytes, calcification, power Doppler (PD) signal, bursitis, and bone irregularities. The images were read by two readers blinded to the clinical information. The intra- and inter-rater reliability for scoring the lesions was excellent (ICC 0.92 to 0.96). Chi square tests were used to compare the frequency of the various lesions between PsA and controls. The sensitivity, specificity and positive predictive value (PPV) of entheseal lesions were computed.

Results: Mean age was 55 ± 10 years, 59% were males, average BMI was 29, and average disease duration was 14.6 years. The frequencies of the various entheseal lesions and their ability to distinguish between PsA and controls are presented in Table 1. The lesions that had the highest PPV were: PD at the enthesis (PD grade greater than 2 (100%) and PD grade greater than 1 (97%)), erosions (89%) and bone proliferation (87%). In general, the sensitivity of was much lower ranging from 0.1% to 27%. No significant differences were found in the frequencies of calcifications or bursitis between PsA patients and controls.

Conclusion: We identified elemental ultrasonographic abnormalities that could distinguish PsA and controls. This information will contribute to the development of a new sonographic score for assessment of enthesitis in patients with PsA that could be used for diagnostic purposes and contribute to new understanding and clinical application of ultrasonographic enthesitis at the bedside.

 

Table 1: The Frequencies, Sensitivities, Specificities and Positive Predictive Values of Entheseal Lesions

 

PsA
(%)

Control (%)

Sensitivity (%)

Specificity (%)

PPV
(%)

p value

Entheseal structural abnormality

13

5

13

95

72

<0.001

Any Enthesophyte

27

18

27

82

60

<0.001

Enthesophyte- grade>1

13

6

13

94

67

<0.001

Enthesophytes – grade >2

6

3

6

97

65

0.003

Non-traction enthesophytes

3

2

3

98

66

0.03

Bony proliferation

3

0.5

3

100

87

<0.001

Any erosion

8

1

8

99

89

<0.001

Any PD signal

9

1

9

99

87

<0.001

PD signal – grade>1

4

0.2

4

100

96

<0.001

PD signal – grade>2

0.8

0.09

0.8

100

90

0.03

Any PD close to enthesitis

7

1

7

99

87

<0.001

PD signal – grade>1 close to enthesitis

3

0.1

3

100

97

<0.001

PD signal – grade >2 close to enthesitis

0.8

0

0.1

100

100

0.008

Calcification

4

4

4

97

54

0.578

Bursitis

1.8

1

2

99

65

0.148

PD – power Doppler

 

 


Disclosure: S. Tom, None; Y. Zhong, None; R. J. Cook, None; S. Z. Aydin, None; G. S. Kaeley, None; L. Eder, None.

To cite this abstract in AMA style:

Tom S, Zhong Y, Cook RJ, Aydin SZ, Kaeley GS, Eder L. Development of an Ultrasonographic Enthesitis Score for Psoriatic Arthritis Patients [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/development-of-an-ultrasonographic-enthesitis-score-for-psoriatic-arthritis-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-an-ultrasonographic-enthesitis-score-for-psoriatic-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology